Mettler-Toledo International Inc. (NYSE:MTD) and Antares Pharma Inc. (NASDAQ:ATRS) compete with each other in the Medical Instruments & Supplies sector. We will analyze and compare their risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation.
Valuation & Earnings
Table 1 shows gross revenue, earnings per share and valuation of the two companies.
Profitability
Table 2 shows the return on assets, return on equity and net margins of the two firms.
Risk & Volatility
Mettler-Toledo International Inc. has a beta of 1.33 and its 33.00% more volatile than Standard and Poors 500. Antares Pharma Inc. has a 0.93 beta and it is 7.00% less volatile than Standard and Poors 500.
Liquidity
The Current Ratio and a Quick Ratio of Mettler-Toledo International Inc. are 1.3 and 0.9. Competitively, Antares Pharma Inc. has 2.9 and 2.5 for Current and Quick Ratio. Antares Pharma Inc.s better ability to pay short and long-term obligations than Mettler-Toledo International Inc.
Analyst Recommendations
Ratings and Recommendations for Mettler-Toledo International Inc. and Antares Pharma Inc. can be find in next table.
Mettler-Toledo International Inc.s downside potential is -9.73% at a $700 consensus price target.
Insider and Institutional Ownership
The shares of both Mettler-Toledo International Inc. and Antares Pharma Inc. are owned by institutional investors at 98.5% and 40.1% respectively. About 0.4% of Mettler-Toledo International Inc.s share are owned by insiders. On the other hand, insiders owned about 2.4% of Antares Pharma Inc.s shares.
Performance
In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.
For the past year Mettler-Toledo International Inc.s stock price has smaller growth than Antares Pharma Inc.
Summary
Mettler-Toledo International Inc. beats Antares Pharma Inc. on 7 of the 12 factors.
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; reaction engineering and real-time analytic systems used in drug and chemical compound development; process analytics instruments used for in-line measurement in production processes; and end-of-line inspection systems used in production and packaging for food, pharmaceutical, and other industries. Its laboratory instruments include laboratory balances, liquid pipetting solutions, titrators, physical value analyzers, and thermal analysis systems, as well as other analytical instruments, such as moisture analyzers and density refractometers; and LabX, a PC-based laboratory embedded software platform. The companys industrial solutions comprise industrial weighing instruments and terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail weighing solutions consist of multiple weighing and food labeling solutions, stand-alone scales, and networked scales and software for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry covering pharmaceutical and biotechnology companies, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; transportation and logistics, metals, and electronics industries; and the academic community. The company markets its products through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was founded in 1991 and is based in Columbus, Ohio.
Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The companys injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache; ZOMA-Jet and Twin-Jector, a needle-free auto injector to deliver human growth hormone treatment to children without the use of a needle; and VIBEX disposable pressure-assisted auto injectors. In addition, the company is developing VIBEX auto injectors for treating anaphylaxis; disposable pen injectors for diabetes and osteoporosis; Makena QuickShot auto injectors for reducing risk of preterm birth; and VIBEX QS Testosterone for testosterone replacement therapy for men who have testosterone deficiency. It has strategic alliances and partnership arrangements with Teva Pharmaceutical Industries, Ltd.; AMAG Pharmaceuticals, Inc.; Ferring Pharmaceuticals Inc.; and Ferring B.V. The company was founded in 1979 and is headquartered in Ewing, New Jersey.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
Read the original:
Contrasting of Mettler-Toledo International Inc. (MTD) and Antares Pharma Inc. (NASDAQ:ATRS) - The Broch Herald
